Arizona State Retirement System Has $5.89 Million Position in STERIS plc (NYSE:STE)

Arizona State Retirement System increased its stake in shares of STERIS plc (NYSE:STE) by 1.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 28,643 shares of the medical equipment provider’s stock after purchasing an additional 322 shares during the quarter. Arizona State Retirement System’s holdings in STERIS were worth $5,888,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the stock. Geode Capital Management LLC raised its position in STERIS by 0.7% during the third quarter. Geode Capital Management LLC now owns 2,303,625 shares of the medical equipment provider’s stock valued at $556,786,000 after acquiring an additional 17,007 shares in the last quarter. Principal Financial Group Inc. raised its position in STERIS by 0.5% during the fourth quarter. Principal Financial Group Inc. now owns 1,119,643 shares of the medical equipment provider’s stock valued at $230,160,000 after acquiring an additional 5,419 shares in the last quarter. Franklin Resources Inc. raised its position in STERIS by 171.2% during the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock valued at $191,370,000 after acquiring an additional 529,308 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in STERIS by 3.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 569,837 shares of the medical equipment provider’s stock valued at $117,136,000 after acquiring an additional 18,384 shares in the last quarter. Finally, Swiss National Bank raised its position in STERIS by 0.3% during the third quarter. Swiss National Bank now owns 293,360 shares of the medical equipment provider’s stock valued at $71,152,000 after acquiring an additional 800 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Stephens reaffirmed an “overweight” rating and set a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, November 8th. JMP Securities reissued a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research report on Thursday, February 6th. Finally, Piper Sandler lifted their price target on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Trading Up 0.3 %

NYSE:STE opened at $233.02 on Friday. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The firm has a market cap of $22.89 billion, a price-to-earnings ratio of 49.47 and a beta of 0.92. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The company’s 50 day moving average is $216.96 and its 200-day moving average is $222.85.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be given a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is currently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.